505 related articles for article (PubMed ID: 26291312)
41. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
Chen M; Liu B; Xiao J; Yang Y; Zhang Y
Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330
[TBL] [Abstract][Full Text] [Related]
42. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
43. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
Yu L; Qiao R; Xu J; Han B; Zhong R
Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
[TBL] [Abstract][Full Text] [Related]
44. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
45. Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer.
Wang L; He Y; Liu W; Bai S; Xiao L; Zhang J; Dhanasekaran SM; Wang Z; Kalyana-Sundaram S; Balbin OA; Shukla S; Lu Y; Lin J; Reddy RM; Carrott PW; Lynch WR; Chang AC; Chinnaiyan AM; Beer DG; Zhang J; Chen G
Oncotarget; 2016 Mar; 7(10):11487-99. PubMed ID: 26862852
[TBL] [Abstract][Full Text] [Related]
46. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
[TBL] [Abstract][Full Text] [Related]
47. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27
Luo G; Liu D; Huang C; Wang M; Xiao X; Zeng F; Wang L; Jiang G
Mol Cancer Res; 2017 Jul; 15(7):789-799. PubMed ID: 28396462
[TBL] [Abstract][Full Text] [Related]
48. LncRNA LINC00520 aggravates cell proliferation and migration in lung adenocarcinoma via a positive feedback loop.
Huang W; Wang X; Wu F; Xu F
BMC Pulm Med; 2021 Sep; 21(1):287. PubMed ID: 34496829
[TBL] [Abstract][Full Text] [Related]
49. The Crosstalk between lncRNA-SNHG7/miRNA-181/cbx7 Modulates Malignant Character in Lung Adenocarcinoma.
Pei YF; He Y; Hu LZ; Zhou B; Xu HY; Liu XQ
Am J Pathol; 2020 Jun; 190(6):1343-1354. PubMed ID: 32201260
[TBL] [Abstract][Full Text] [Related]
50. LncRNA LUADT1 sponges miR-15a-3p to upregulate Twist1 in small cell lung cancer.
Wang D; Wu W; Huang W; Wang J; Luo L; Tang D
BMC Pulm Med; 2019 Dec; 19(1):246. PubMed ID: 31842825
[TBL] [Abstract][Full Text] [Related]
51. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
[TBL] [Abstract][Full Text] [Related]
52. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung.
Miao H; Chen D; Li R; Hu J; Chen Y; Xu C; Wen Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324975
[TBL] [Abstract][Full Text] [Related]
53. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
Wang X; Sehgal L; Jain N; Khashab T; Mathur R; Samaniego F
J Transl Med; 2016 Dec; 14(1):346. PubMed ID: 27998273
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
55. Long noncoding RNA LMO7DN inhibits cell proliferation by regulating the cell cycle in lung adenocarcinoma.
Zeng L; Chen Y; Yuan J; Lyu X; Zhang L; Yan X; Mi K; Li N; Xing F; Yang S
Pathol Res Pract; 2021 Jul; 223():153475. PubMed ID: 33991849
[TBL] [Abstract][Full Text] [Related]
56. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
57. Down-regulation of lncRNA LUADT1 suppresses cervical cancer cell growth by sequestering microRNA-1207-5p.
Zhang Q; Zheng J; Liu L
Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):321-331. PubMed ID: 35538030
[TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
[TBL] [Abstract][Full Text] [Related]
59. ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma.
Zhang Q; Zheng X; Sun Q; Shi R; Wang J; Zhu B; Xu L; Zhang G; Ren B
Biochem Biophys Res Commun; 2017 Sep; 490(4):1189-1196. PubMed ID: 28669730
[TBL] [Abstract][Full Text] [Related]
60. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
